StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — ICICI Securities

BUYAarti Pharmalabs Limited
Aarti Pharmalabs share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)1 Nov 2026via Institutional / Brokerage Research

Entry₹873.2Inferred
Target₹1,035
Total upside +18.53%
Stop lossNot given
CMP₹929.11d ago
Active+6.40%+11.40%upside left 12 mo left
Follow ICICI Securities for new calls(64% target hit, 1085 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 2 other Long-term calls on AARTIPHARMSee 542 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:24 pm IST
9 supporting5 neutral0 opposing
Supports the BUY call (9)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

2 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·4 Nov · 3d ago

Aarti Pharmalabs Q2 FY27 slides: revenue surges 47% on capacity ramp By Investing.com

NewsGoogle News·29 Oct · 1w ago

(opens in new tab)

Earnings call transcript: Aarti Pharmalabs Q2 2026 revenue jumps 47% as stock rises By Investing.com

NewsGoogle News·29 Oct · 1w ago

(opens in new tab)

Aarti Pharmalabs shares Q2 FY27 results with revenue up by 46.8%

NewsGoogle News·29 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (5)

Appointment of Smt. Vibha Thakkar as the new Chief Financial Officer.

NSE · Appointment·28 Oct · 1w ago

(opens in new tab)

Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·28 Oct · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Pharmalabs

All analyst calls on Aarti Pharmalabs

More from ICICI Securities

Every call and its outcome